Patients with celiac disease face an increased risk of developing any chronic liver disease. This risk increase can persist for at least 25 years after celiac diagnosis. The findings, published in The Lancet Regional Health—Europe, underscore clinical vigilance for signs of liver disease in patients with celiac disease to prevent major adverse liver outcomes.
Super-resolution microscopy shows how therapeutic antibodies work against cancer cells
In blood cancers such as chronic lymphocytic leukemia, B cells of the immune system multiply uncontrollably. One form of therapy involves labeling the CD20 protein on the surface of the B cells with customized antibodies. This triggers a chain of immunological reactions and ultimately leads to the destruction of the cancer cells.
Tongue cancer organoids reveal secrets of chemotherapy resistance
Oral cancer is an increasingly prevalent disease worldwide, with over 300,000 new cases diagnosed each year. Among oral cancers, tongue cancer (TC) is the most common type and often carries a poor prognosis.
Antibody discovery may lead to a cure for age-related lung diseases
Research led by Brock University has found a possible cure for lung diseases typically found in older adults, such as pulmonary fibrosis. The findings are published in the journal Aging Cell.
T cells’ capability to fully prevent acute viral infections opens new avenues for vaccine development
Scientists from Duke-NUS Medical School and the Singapore General Hospital have discovered that T cells—white blood cells that can destroy harmful pathogens—can completely prevent viral infection, to an extent previously thought only possible due to neutralizing antibodies.
Data-driven study reveals falling use of antiseizure drug in pregnancy
University of Liverpool researchers have contributed to the largest study to date on sodium valproate use. This significant report shows decreased use in women of childbearing age and during pregnancy, as well as young men, due to safety concerns.
Lung cancer trial reveals 40% drop in deaths using biomarker testing
New research from the University of St Andrews School of Medicine has found that biomarker testing in individuals at risk of lung cancer led to a major reduction in deaths.
AI analysis reveals four long COVID patient subgroups and needs
Across the United States, no hospital is the same. Equipment, staffing, technical capabilities, and patient populations can all differ. So, while the profiles developed for people with common conditions may seem universal, the reality is that there are nuances that require individual attention, both in the make-up of the patients being seen and the situations of the hospitals providing their care.
Cambodian man dies from bird flu
A 28-year-old Cambodian man died from bird flu on Friday after eating sick chickens, the health ministry said.
New AI model helps predict veteran suicide risk
U.S. Army veteran suicides can be predicted with “moderate to good accuracy” by applying artificial intelligence (AI) to data available before veterans leave service, according to a new study led by Chris J. Kennedy at Massachusetts General Hospital and co-authored by a University of Hawaiʻi at Mānoa Department of Psychology faculty member.